Investigations into the azo reducing activity of a common colonic microorganism

International Journal of Pharmaceutics

Volumn 157, Issue 1, 1997, Pages 61-71

  Bragger, J L ^a   Lloyd, A W ^b   Soozandehfar, S H ^b   Bloomfield, S F ^a   Marriott, C ^a   Martin, G P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Azo dyes; Azo reduction; Bacteroides fragilis; Colonic drug delivery; Redox potential

Indexed keywords

AMARANTH; AZO COMPOUND; AZO DYE; AZO REDUCTASE; BENZYLVIOLOGEN; TARTRAZINE;

ARTICLE; BACTEROIDES FRAGILIS; COLON; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; EUBACTERIUM; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PH; PRIORITY JOURNAL; REDUCTION;

EID: 0030813428     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00214-7     Document Type: Article

References (39)

1. Azad Khan A.K., Guthrie G., Johnston H.H., Truelove S.C., Williamson D.H. Tissue and bacterial splitting of sulphasalazine. Clinical Science. 64:1983;349-354.
2. Bogoslowski B.M. A new method of obtaining symmetrical azo compounds. Zhurnal Obsshchei Khimii (Journal of General Chemistry). 16:1946;193-197.
3. Borriello P., Hudson M., Hill M. Investigation of the gastrointestinal bacterial flora. Clinics in Gastroenterology. 7:1978;329-349.
4. Bronsted H., Kopecek J. Hydrogels for site-specific drug delivery to the colon. Pharmaceutical Research. 9:1992;1540-1545.
5. Brown J.P. Role of gut bacterial flora in nutrition and health: A review of recent advances in bacteriological techniques, metabolism, and factors affecting flora composition. CRC Critical Reviews in Food Science and Nutrition. 8:1977;292-335.
6. Brown J.P. Reduction of polymeric azo and nitro dyes by intestinal bacteria. Applied and Environmental Microbiology. 41:1981;1283-1286.
7. Cerniglia C.E., Zhou Z., Manning B.W., Federle T.W., Heflich R.H. Mutagenic activation of the bezidine-based dye Direct Black 38 by human intestinal microflora. Mutation Research. 175:1986;11-16.
8. Chung K.-T., Fulk G.E., Egan M. Reduction of azo dyes by intestinal anaerobes. Applied and Environmental Microbiology. 35:1978;558-562.
9. Chung K.-T. The significance of azo-reduction in the mutagenesis and carcinogenesis of azo dyes. Mutation Research. 114:1982;269-281.
10. Chung K.-T., Stevens S.E. Jr., Cerniglia C.E. The reduction of azo dyes by the intestinal microflora. Critical Reviews in Microbiology. 18:1992;175-190.
11. Dubin P., Wright K.L. Reduction of azo food dyes in cultures of P. vulgaris. Xenobiotica. 5:1975;563-571.
12. Evans D.F., Pye G., Bramley R., Clark A.G., Dyson T.J. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 29:1988;1035-1041.
13. Finegold S.M., Attebery H.R., Sutter V.L. Effect of diet on human fecal flora: Comparison of Japanese and American diets. American Journal of Clinical Nutrition. 27:1974;1456-1469.
14. Gingell R., Walker R. Mechanisms of azo reduction by Streptococcus faecalis. II. The role of soluble flavins. Xenobiotica. 1:1971;231-239.
15. Holdeman, L.V., Moore, W.E.C. (Eds.), 1973. Anaerobe Laboratory Manual, 2nd ed. Virginia Polytechnic Institute and State University, Blacksburg, VA.
16. Kimura Y., Makita Y., Kumagai T., Yamane H., Kitao T., Sasatani H., Kins I. Degradation of azo-containing polyurethane by the action of intestinal flora: its mechanism and application as a drug delivery system. Polymer. 33:1992;5294-5299.
17. Kopeckova P., Kopecek J. Release of 5-aminosalicylic acid from bioadhesive N-(2-hydroxypropyl)methacrylamide copolymers by azoreductases in vitro. Makromolecular Chemistry. 191:1994;2037-2045.
18. Kumar, G.S. (Ed.), 1992. Azo Functional Polymers: Functional Group Approach in Macromolecular Design. Technomic Publishing, PA.
19. Levine W.G., Raza H. Mechanism of azo reduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN. Drug Metab. Disp. 16:1988;441-448.
20. Levine W.G., Stoddart A., Zbaida S. Multiple mechanisms in hepatic-microsomal azoreduction. Xenobiotica. 22:1992;1111-1120.
21. Lloyd A.W., Martin G.P., Soozandehfar S.H. Azopolymers: a means of colon specific drug delivery? International Journal of Pharmaceutics. 106:1994;255-260.
22. Peppercorn M.A., Goldman P. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. Journal of Pharmacology and Experimental Therapeutics. 181:1972;555-562.
23. Radomski J.L., Mellinger T.J. The absorption, fate and excretion in rats of the water-soluble azo dyes, FD and C Red No. 2, FD and C Red No. 4 and FD and C Yellow No. 6. Journal of Pharmacology and Experimental Therapeutics. 136:1962;259-266.
24. Rafii F., Cerniglia C.E. An anaerobic nondenaturing gel assay for the detection of azoreductase from anaerobic bacteria. Journal of Microbiological Methods. 12:1990;139-148.
25. Rafii F., Cerniglia C.E. Localization of the azoreductase of Clostridium perfringens by immuno-electron microscopy. Current Microbiology. 27:1993;143-145.
26. Rafii F., Franklin W., Cerniglia C.E. Azoreductase activity of anaerobic bacteria isolated from human intestinal flora. Applied and Environmental Microbiology. 56:1990;2146-2151.
27. Rafii F., Smith D.B., Benson R.W., Cerniglia C.E. Immunological homology among azoreductases from Clostridium and Eubacterium strains isolated from human intestinal microflora. Journal of Basic Microbiology. 32:1992;99-105.
28. Roxon J.J., Ryan A.J., Wright S.E. Enzymatic reduction of tartrazine by Proteus vulgaris from rats. Food and Cosmetic Toxicology. 5:1967;645-656.
29. Saffran M., Kumar G.S., Savariar C., Burnham J.C., Williams F., Neckers D.C. A new approach to the oral administration of insulin and other peptide drugs. Science. 233:1986;1081-1084.
30. Schacht E., Gevaert A., Kenaway E.R., Molly K., Verstraete W., Adriaensens P., Carleer R., Gelan J. Polymers for colon specific drug delivery. Journal of Controlled Release. 39:1996;327-338.
31. Schroder H., Johansson A.K. Redox potential in caecal contents of the rat and azo reduction of salicyl-azo-sulphapyridine. Xenobiotica. 3:1973;233-246.
32. Sisley P., Porscher C. Du sort des matie'res colorantes dans l'organisme animal. C.r. hebd. Se'anc. Acad. Sci., Paris. 152:1911;1062-1065.
33. Van den Mooter G., Samyn C., Kinget R. Azo polymers for colon-specific drug delivery. II: Influence of the type of azo polymer on the degradation by intestinal microflora. International Journal of Pharmaceutics. 97:1993;133-139.
34. Van den Mooter G., Samyn C., Kinget R. Characterization of colon-specific azo polymers: A study of the swelling properties and the permeability of isolated polymer films. International Journal of Pharmaceutics. 111:1994;127-136.
35. Van den Mooter G., Offringa M., Kalala W., Samyn C., Kinget R. Synthesis and evaluation of new linear azo-polymers for colonic targeting. S.T.P. Pharma Sciences. 5:1995;36-40.
36. Walker R. The metabolims of azo compounds: a review of the literature. Fd. Cosmet. Toxicol. 8:1970;659-676.
37. Zbaida S., Brewer C.F., Levine W.G. Reactivity of azo dye substrates is determined by their electron densities and redox potentials. Drug Metabolism and Disposition. 22:1994;412-418.
38. Zbaida S., Levine W.G. Role of electronic factors in binding and reduction of azo dyes by hepatic microsomes. Journal of Pharmacology and Experimental Therapeutics. 260:1991;554-561.
39. Zimmerman T., Kulla H.G., Leisinger T. Properties of purified Orange II azoreductase, the enzyme initiating azo dye degradation by Pseudomonas KF 46. European Journal of Biochemistry. 129:1982;197-203.